NCT00050427 arm group 93dd4de5cddba2c733c65f233097f05a [clinicaltrials_resource:NCT00050427/arm-group/93dd4de5cddba2c733c65f233097f05a]
arm group [clinicaltrials_vocabulary:arm-group]
NCT00050427 arm group 93dd4de5cddba2c733c65f233097f05a [clinicaltrials_resource:NCT00050427/arm-group/93dd4de5cddba2c733c65f233097f05a]
Bio2RDF identifier
NCT00050427/arm-group/93dd4de5cddba2c733c65f233097f05a
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... dd4de5cddba2c733c65f233097f05a
description [clinicaltrials_vocabulary:description]
ET743 1 300 mcg/m2 3 hour i.v ...... to each trabectedin infusion.
identifier
clinicaltrials_resource:NCT00050427/arm-group/93dd4de5cddba2c733c65f233097f05a
title
NCT00050427 arm group 93dd4de5cddba2c733c65f233097f05a
@en
type
label
NCT00050427 arm group 93dd4de5 ...... d4de5cddba2c733c65f233097f05a]
@en